Jennerex Announces Nature Medicine Publication Highlighting Randomized Overall Survival Benefit of Lead Product Candidate, Pexa-Vec (JX-594) in Patients with Advanced Hepatocellular Carcinoma (HCC)
2013.02.13
Download
© Lee's Pharmaceutical Holdings Limited
Terms of Use
|
Privacy Statement
Designed by YSD
